The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose , HCV and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.